Female Infertility Panel
Use
This test is designed for individuals with relevant clinical features who have been diagnosed or suspected of having female infertility. It targets women who experience infertility despite 12 or more months of regular, unprotected intercourse. The test is particularly suitable for cases where hypogonadotropic or hypergonadotropic hypogonadism is present, and a genetic diagnosis is required to inform treatment and management decisions.
Special Instructions
The test can be ordered via the Exome or Genome Platforms with various specimen types including Blood, DNA, Buccal, Saliva, and Tissue for Exome, and Blood or DNA for Genome. It offers STAT testing with a turnaround time of 7 - 16 days if required urgently. A form can be downloaded for fax ordering if online order is not possible.
Limitations
The test has not been cleared or approved by the US Food and Drug Administration. Its clinical validity and utility are based on careful validation according to CLIA standards. Turnaround times might vary based on the type of platform used (Exome or Genome), and might be extended if additional reflex or follow-up testing is required.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided